CALC Archived Articles
CalciMedica Inc. (NASDAQ:CALC): Leveraging Novel CRAC Channel Inhibition to Tackle Acute and Chronic Inflammatory Conditions
Published on March 15, 2025
CalciMedica, Inc. (NASDAQ:CALC): Advancing Novel CRAC Channel Inhibition Therapies for Acute and Chronic Inflammatory Conditions
Published on November 28, 2024
CalciMedica, Inc. (NASDAQ:CALC): A Promising CRAC Channel Inhibitor Targeting Acute and Chronic Inflammatory Diseases
Published on September 24, 2024